Column Group L P - Net Worth and Insider Trading
Column Group L P Net Worth
The estimated net worth of Column Group L P is at least $284 Million dollars as of 2024-12-26. Column Group L P is the 10% Owner of Constellation Pharmaceuticals Inc and owns about 6,230,638 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $212 Million. Column Group L P is the 10% Owner of Immune Design Corp and owns about 6,642,942 shares of Immune Design Corp (IMDZ) stock worth over $39 Million. Column Group L P is also the Director, 10% Owner of NGM Biopharmaceuticals Inc and owns about 21,743,413 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $33 Million. Details can be seen in Column Group L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Column Group L P has not made any transactions after 2023-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Column Group L P
Column Group L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Column Group L P owns 4 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Nurix Therapeutics Inc (NRIX) , and Constellation Pharmaceuticals Inc (CNST) among others .
Click here to see the complete history of Column Group L P’s form 4 insider trades.
Insider Ownership Summary of Column Group L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2023-11-16 | 10 percent owner |
| NRIX | Nurix Therapeutics Inc | 2021-05-07 | 10 percent owner |
| CNST | Constellation Pharmaceuticals Inc | 2021-02-17 | 10 percent owner |
 | | 2019-04-02 | 10 percent owner |
Column Group L P Latest Holdings Summary
Column Group L P currently owns a total of 3 stocks. Among these stocks, Column Group L P owns 6,230,638 shares of Constellation Pharmaceuticals Inc (CNST) as of February 17, 2021, with a value of $212 Million and a weighting of 74.54%. Column Group L P owns 6,642,942 shares of Immune Design Corp (IMDZ) as of October 27, 2017, with a value of $39 Million and a weighting of 13.68%. Column Group L P also owns 21,743,413 shares of NGM Biopharmaceuticals Inc (NGM) as of November 16, 2023, with a value of $33 Million and a weighting of 11.79%.
Latest Holdings of Column Group L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNST | Constellation Pharmaceuticals Inc | 2021-02-17 | 6,230,638 | 33.99 | 211,779,386 |
| IMDZ | Immune Design Corp | 2017-10-27 | 6,642,942 | 5.85 | 38,861,211 |
| NGM | NGM Biopharmaceuticals Inc | 2023-11-16 | 21,743,413 | 1.54 | 33,484,856 |
Holding Weightings of Column Group L P
Column Group L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Column Group L P has made a total of 4 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Constellation Pharmaceuticals Inc is the sale of 10,000 shares on February 17, 2021, which brought Column Group L P around $369,500.
According to the SEC Form 4 filings, Column Group L P has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the acquisition of 2,681,000 shares on October 27, 2017, which cost Column Group L P around $11 Million.
According to the SEC Form 4 filings, Column Group L P has made a total of 87 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 87 buys and 0 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the acquisition of 22,631 shares on November 16, 2023, which cost Column Group L P around $15,615.
Insider Trading History of Column Group L P
- 1
Column Group L P Trading Performance
GuruFocus tracks the stock performance after each of Column Group L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Column Group L P is 21.57%. GuruFocus also compares Column Group L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Column Group L P within 3 months outperforms 68 times out of 121 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Column Group L P's insider trading performs compared to the benchmark.
Performance of Column Group L P
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.88 | | | | | |
| Relative Return to S&P 500(%) | 7.08 | | | | | |
Column Group L P Ownership Network
Column Group L P Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
Column Group L P is the 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , Chief Financial Officer Jean-frederic Viret , and Principal Accounting Officer Irene Perlich .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, Column Group L P made 3 insider transaction in NGM Biopharmaceuticals Inc (NGM) with a net purchase of 67,893. Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 26,811 shares made by David V Goeddel ,
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
Column Group L P Mailing Address
Above is the net worth, insider trading, and ownership report for Column Group L P. You might contact Column Group L P via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
